Yuyu Pharma Inc (000220) Stock Price & News

000220:KRX

Yuyu Pharma Inc

₩3,795.00

-0.13%

(-5.00) 1D

Nov 13, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 000220...

Open

₩3,810

High

₩3,830

Low

₩3,750

Mkt. cap

70.46B

Avg. vol.

46.74K

Volume

40.07K

Dividend

3.03%

Quarterly dividend

₩29

Ex-dividend date

Dec 27, 2024

P/E ratio

5.67

52-wk high

₩5,100

52-wk low

₩3,320

EPS

₩669

Shares outstanding

15.75M

No. of employees

243

Open

₩3,810

High

₩3,830

Low

₩3,750

Mkt. cap

70.46B

Avg. vol.

46.74K

Volume

40.07K

Dividend

3.03%

Quarterly dividend

₩29

Ex-dividend date

Dec 27, 2024

P/E ratio

5.67

52-wk high

₩5,100

52-wk low

₩3,320

EPS

₩669

Shares outstanding

15.75M

No. of employees

243

Related stocks

Samil Pharmaceutical Co Ltd

JW Pharmaceutical Corp

₩23,650.00

+0.85%

News stories

From web sources and news partners

Reuters

1 hour ago

Goldman Sachs sees S&P 500 rising to 8,700 next year despite slower earnings growth

Yahoo Finance

26 minutes ago

Stock market today: S&P 500, Nasdaq turn lower as wholesale inflation rises, Nvidia stock falls

CNBC

18 hours ago

Nasdaq Composite slides as Nvidia shares tumble on Jensen Huang’s exit; oil prices jump

24/7 Wall St.

1 hour ago

He Wants Anthropic in His S&P 500 401(k) as Soon as It Goes Public. One Index Rule Could Keep It Out for at Least 12 Months. Even Then, His Fund May Never Own It

About Yuyu Pharma Inc

CEO-

Employees243

Founded1941

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websiteyuyu.co.kr

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	37.79B	34.34B	35.54B	36.70B
Cost of goods sold	23.00B	22.54B	21.04B	22.11B
Cost of revenue	23.00B	22.54B	21.04B	22.11B
Research and development expenses	914.90M	1.15B	703.42M	781.89M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	8.71B	10.17B	8.95B	9.33B
Operating expense	9.81B	11.93B	10.19B	10.59B
Total operating expenses	32.81B	34.47B	31.24B	32.69B
Operating income	4.99B	-129.07M	4.30B	4.00B
Other non operating income	56.65M	-1.13B	863.61M	-184.40M
EBT including unusual items	4.82B	202.03M	3.97B	4.13B
EBT excluding unusual items	4.77B	-1.11B	4.99B	3.68B
Income tax expense	504.29M	-1.00B	620.45M	574.52M
Effective tax rate	10.46%	-496.97%	15.62%	13.91%
Other operating expenses	18.27M	76.24M	40.94M	36.86M
Net income	3.98B	1.39B	3.49B	3.65B
Net profit margin	10.52%	4.03%	9.82%	9.95%
Earnings per share	-	-	-	-
Interest and investment income	136.07M	529.96M	286.44M	226.76M
Interest expense	-540.35M	-547.07M	-474.32M	-436.45M
Net interest expenses	-404.28M	-17.11M	-187.88M	-209.69M
Depreciation and amortization charges	320.96M	403.34M	334.87M	409.27M
EBITDA	6.34B	1.33B	5.68B	5.46B
Gain or loss from assets sale	-13.34M	-	-499.00K	-3.19M

Ask anything